Piper Sandler Downgrades Aadi Biosciences(AADI.US) to Hold Rating, Cuts Target Price to $1.75
Aadi Bioscience Analyst Ratings
TD Cowen Maintains Aadi Biosciences(AADI.US) With Hold Rating
H.C. Wainwright Maintains Aadi Biosciences(AADI.US) With Hold Rating
TD Cowen Downgrades Aadi Biosciences(AADI.US) to Hold Rating
Aadi Bioscience Analyst Ratings
Aadi Bioscience Analyst Ratings
HC Wainwright & Co. Maintains Buy on Aadi Bioscience, Lowers Price Target to $36
Aadi Bioscience Analyst Ratings
Aadi Bioscience Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Aadi Bioscience, Maintains $45 Price Target
HC Wainwright & Co. Maintains Buy on Aadi Bioscience, Lowers Price Target to $45
No Data